Examples include: Medical contraindications to GLP-1 therapy Lack of clinical supervision No structured plan for muscle preservation Hormonal status not yet evaluated Reducing the dose does not remove contraindications or eliminate underlying medical risks
These findings highlight the importance of understanding the intricate interplay between DPP-4, bone metabolism, and systemic health [9, 11,12,13,14,15,16,17,18,19]
Affected children often have inflammation of the liver and/or cirrhosis
The new-fangled concept of recommending glutathione as an adjuvant (orally, topically or as mesotherapy) for melasma, freckles and postinflammatory hyperpigmentation is based on its depigmenting properties detailed in [Box 2]
Pancreatitis is listed as a rare but serious adverse event associated with GLP-1 receptor agonists, including tirzepatide
Generally solitary, a melanotic lip macula is seen more frequently in adult women, but it also occurs in men and young people